S&P 500

5.303,27

0,12%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Cingulate Inc (CING)
Cingulate Inc (CING) Notícias

CING

Cingulate (CING)

Cingulate Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CING

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/05/2024	08:00	GlobeNewswire Inc.	Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update	NASDAQ:CING	Cingulate Inc
30/04/2024	06:45	GlobeNewswire Inc.	Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access	NASDAQ:CING	Cingulate Inc
16/04/2024	18:00	GlobeNewswire Inc.	Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024	NASDAQ:CING	Cingulate Inc
01/04/2024	09:00	GlobeNewswire Inc.	Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update	NASDAQ:CING	Cingulate Inc
19/03/2024	17:45	GlobeNewswire Inc.	Cingulate to Participate in Benzinga All Live Access Event	NASDAQ:CING	Cingulate Inc
06/03/2024	20:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CING	Cingulate Inc
06/03/2024	08:45	GlobeNewswire Inc.	Cingulate to Attend DCAT Week 2024 in New York City	NASDAQ:CING	Cingulate Inc
26/02/2024	09:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CING	Cingulate Inc
14/02/2024	19:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CING	Cingulate Inc
13/02/2024	08:45	GlobeNewswire Inc.	Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors	NASDAQ:CING	Cingulate Inc
09/02/2024	11:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CING	Cingulate Inc
09/02/2024	08:28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:CING	Cingulate Inc
06/02/2024	18:15	GlobeNewswire Inc.	Cingulate Announces Closing of $7.5 Million Public Offering	NASDAQ:CING	Cingulate Inc
05/02/2024	19:00	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:CING	Cingulate Inc
05/02/2024	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CING	Cingulate Inc
02/02/2024	11:15	GlobeNewswire Inc.	Cingulate Announces Pricing of $7.5 Million Public Offering	NASDAQ:CING	Cingulate Inc
29/01/2024	10:59	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:CING	Cingulate Inc
29/01/2024	10:00	GlobeNewswire Inc.	Longtime Cingulate Controller Jennifer Callahan Promoted to CFO	NASDAQ:CING	Cingulate Inc
29/01/2024	08:45	GlobeNewswire Inc.	Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market	NASDAQ:CING	Cingulate Inc
12/01/2024	19:03	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:CING	Cingulate Inc
06/12/2023	11:00	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:CING	Cingulate Inc
01/12/2023	11:00	GlobeNewswire Inc.	Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)	NASDAQ:CING	Cingulate Inc
13/11/2023	18:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CING	Cingulate Inc
13/11/2023	18:15	GlobeNewswire Inc.	Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update	NASDAQ:CING	Cingulate Inc
17/10/2023	15:22	GlobeNewswire Inc.	Cingulate to Host CNS Key Opinion Leader Panel in New York City	NASDAQ:CING	Cingulate Inc
02/10/2023	17:30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CING	Cingulate Inc
22/09/2023	09:06	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CING	Cingulate Inc
21/09/2023	14:30	GlobeNewswire Inc.	Cingulate Inc. to Present at the LD Micro Main Event XVI	NASDAQ:CING	Cingulate Inc
13/09/2023	17:15	GlobeNewswire Inc.	Cingulate Announces Closing of $4.0 Million Public Offering	NASDAQ:CING	Cingulate Inc
11/09/2023	10:22	GlobeNewswire Inc.	Cingulate Announces Pricing of $4.0 Million Public Offering	NASDAQ:CING	Cingulate Inc